Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)
NCT04583358
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
105
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
AMT-101 (oral)
OTHER:
Placebo (oral)
Sponsor
Applied Molecular Transport